Politics

Politics By Nicholas Florko

Despite its high price tag, the new Alzheimer’s drug isn’t reigniting the drug pricing debate

Matt's Take By Matthew Herper

By approving Biogen’s Alzheimer’s drug, the FDA is shifting its rules. That is a giant risk

Pharmalot By Ed Silverman

Drug makers argue an HHS rule would penalize them for offering co-pay coupons

Politics By Rachel Cohrs

Health care providers hope to cash in through Congress’ new earmark process

Politics By Megan Molteni

California could become first state to mandate biosecurity screening by mail-order DNA companies

Politics By Nicholas Florko

Democrats call on FTC to investigate AbbVie’s Humira pricing strategy

Politics By Nicholas Florko

Congress is ready to grill AbbVie’s CEO over drug pricing 

Exclusive By Nicholas Florko

Abandoned Trump order on the bioeconomy highlights a path forward for Biden — but with mixed reviews 

Politics By Rachel Cohrs and Casey Ross

Telehealth companies are fueling a lobbying frenzy to protect their Covid boom

Politics By Nicholas Florko

Pharma showers Menendez with rare, off-cycle burst of campaign cash as Democrats eye drug pricing reforms 

Politics By Lev Facher

White House aims to give 70% of American adults at least one Covid-19 vaccine dose by July 4

Politics By Rachel Cohrs

Biden’s Medicaid pressure tactics could put his team at odds with hospitals

Politics By Rachel Cohrs

Top Senate Democrat heads back to drawing board on drug pricing

Politics By Lev Facher

Do public health officials need to be political activists? A fight over an HIV crisis renews the question

Politics By Lev Facher

Lander fends off controversy, pledges broader access to STEM careers during Senate confirmation hearing

Politics By Lev Facher

In his biggest speech yet, Biden pitches a new health agency to help ‘end cancer as we know it’

Politics By Rachel Cohrs

Biden called for drug pricing reform this year. But it’s an empty call

Politics By Lev Facher

Biden administration will allow nearly all providers to prescribe buprenorphine

Politics By Rachel Cohrs

Drug pricing déjà vu: Now it’s Democrats struggling to unite on the issue 

Politics By Nicholas Florko

The FDA will this week decide whether to ban menthol cigarettes — but most likely, the fight is just getting started 

Politics By Nicholas Florko and Rachel Cohrs

Worried drug pricing reform might be left behind, Democrat pushes Biden to make clear his support

Politics By Rachel Cohrs

Why hospitals hate Bernie Sanders’ latest health reform push

Exclusive By Rachel Cohrs and Lev Facher

Top Senate Republican holds up Biden’s CMS nominee over Texas Medicaid waiver

Exclusive By Nicholas Florko

Biden officials met privately with 3M, AmerisourceBergen, PhRMA, and more to debate shoring up the national stockpile 

Politics By Rachel Cohrs

The lobbying juggernaut the American Hospital Association is losing its top advocate at a critical moment for the industry

Health By Nicholas St. Fleur

In Q&A, Vice President Harris calls for urgent action on the Black maternal health crisis 

Politics By Nicholas Florko

Hints emerge about a key Senate committee’s plans for health care

First Opinion By Ethan Dmitrovsky

Rethinking triage in an era of vaccine nationalism

Politics By Nicholas Florko

PhRMA chief talks strategy — and he’s surprisingly optimistic about drug pricing reform